Active Ingredient(s):Ozanimod Hydrochloride FDA Approved: * March 25, 2020 Pharm Company: *CELGENE INTL Category:Multiple Sclerosis
Ozanimod, sold under the brand name Zeposia, is an immunomodulatory medication for the treatment of relapsing multiple sclerosis and ulcerative colitis. It acts as a sphingosine-1-phosphate (S1P) receptor agonist, sequestering lymphocytes to peripheral lymphoid organs and away from their sites of chronic inflammation.
The most common adverse reactions are upper respiratory infection, hepatic transam...
* May have multiple approval dates, manufacturers, or labelers.